CHD2 and acute myeloid leukemia: Almost half (45%, Hypergeometric test P = 1.7 E-93) of the co-expressed genes in the TCGA AML cohort are also direct CHD2 targets (Figure 6(c)), suggesting that CHD2 promotes AML-specific transcription.